The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2026 | Patient voice essential for research trial design and treatment development
Andrea Dwyer, MPH, University of Colorado Cancer Center, Aurora, CO, discusses the importance of the patient voice and perspective for future research. Patient/caregiver experience should inform trial design, global initiatives, and policy. Advocacy organizations representing patients must participate alongside scientists and medical community. To effectively design research trials, treatment options, and survivorship programs, they must be grounded in authentic patient experience, ensuring holistic approaches to cancer care worldwide.This interview took place at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
